Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Reporter: Aviva Lev-Ari, PhD, RN

Living standards in ASEAN countries are rapidly improving. In Indonesia, GDP per capita has doubled in the past 5 years and mid-income population is expected to double to 52 million by 2015. Indonesia and Southeast Asia represents great opportunities for companies in the pharmaceutical industry.

Hear from industry leaders at the CPhI Southeast Asia Pharmaceutical Summit, 20-21 March 2013. Confirmed speakers include:

• Mr. Marcus Pitt, Chief Executive Officer, SOHO Group (Indonesia)
• Mr. Rachod Thakolsri, Managing Director, BioLab (Thailand)
• Mr. Thomas Runkel, Vice President Asia Pacific and Indonesia, Actavis (Indonesia)
• Dato’ Eisah Rahman, Senior Director – National Pharmaceutical Control Bureau, Ministry of Health (Malaysia)
• Mr. Shanti Shamdasani, Director – Government & Policy Affairs ASEAN,Johnson & Johnson (Indonesia)
• Senior Representative, Thai Food and Drug Administration (Thailand)
• Mr. Johny Nurdi, Corporate Medical Director, Eka Hospital (Thailand)
• Mr. Jamaludin Elis, Commercial Director, Pharmaniaga (Malaysia)
• Mr. Mandar Kodgule, Vice President – Global IP and Strategic Planning, Wockhardt (India)
• Dr. Subowo Timboel, Chief Operating Officer, MENSA Group (Indonesia)
• Dr. Jong-Hyeon Han, General Manager, Dong-A Pharmaceutical (South Korea)
• Mr. Jonathan Sudharta, Business Development Director,  MENSA Group (Indonesia)
• Dr. Jennifer Jian Kang, Senior Patent Attorney, Bayer (China)
• Ms. Lynn Robles, Technical Director, Phillippines Chamber of Pharmaceutical Industry (Phillippines)
• Dr. Himanshu Gadgil, Vice President – R&D, Intas Biopharmaceuticals (India)
• Mr. Wouter Claerhout, Marketing Director, DSM Nutritional Products (Singapore)
• Mr. Philip Ytac, National Sales Manager, Getz Pharma (Phillippines)
• Dr. Ziqiang Gu, Consultant, U.S. Pharmacopeial Convention (USP) (USA)
• Mr. Anand Srinivasan, Country Manager, IMS Health (Indonesia)
• Mr. Bernardo Belen, Former Marketing Director, Invida (Philippines)

PHARMA SUMMIT PROGRAM HIGHLIGHTS

 Download Brochure

http://www.cphi-sea.com/c/document_library/get_file?uuid=631b5963-8bf6-4935-ad9b-46b72c30506c&groupId=2223086

Get the latest information on the rapidly growing ASEAN pharma market at the CPhI Southeast Asia Pharmaceutical Summit, 20-21 March 2013. Topics include:

–    ASEAN Harmonisation: The evolving roadmap for the regional pharmaceutical industry

–    Cross-border Trade & Policy Arbitrage: Understanding the framework and how to navigate the diverse landscape

–    IPR Protection: How can protection of intellectual property and rights develop a foundation for innovation?

–    The Healthcare Perspective: Trends in health and patient care and what this means to the pharmaceutical industry

–    Innovation & Consumer Trends: What are the correlations and how do trends drive innovation in product, technology and delivery?

–    Pharma Marketing: What this really means in accessing Southeast Asia

–    The Future of Generics: Will the rise and tide of generics continue?

–    US FDA Quality by Design Practices: Establishing Manufacturing Excellence

–    Nutraceuticals: Outlook on forthcoming opportunities and challenges

–    Biopharmaceuticals: Discovering the opportunities in Southeast Asia

CPhI Southeast Asia Exhibitor List – 2013

Gain access to the ASEAN pharma market. Meet leading ingredients, packaging and machinery providers, including the following exhibitors as of January 22, 2013:

CCPIT Pavilion

CCCMHPIE Pavilion